1. Guest, the 'News in Brief' for the week beginning 19th September 2022 is here.
    Dismiss Notice
  2. Welcome! To read the Core Purpose and Values of our forum, click here.
    Dismiss Notice

covid-19

Page 1 of 12
  1. John Mac
    Thread

    Plasma proteomic signature predicts who will get persistent symptoms following SARS-CoV-2 infection, Captur et al, 2022

    Background The majority of those infected by ancestral Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) during the UK first wave...
    Thread by: John Mac, Sep 28, 2022 at 3:42 PM, 5 replies, in forum: Long Covid research
  2. SNT Gatchaman
    Thread

    SARS-CoV-2 Spike protein promotes vWF secretion and thrombosis via endothelial cytoskeleton-associated protein 4 (CKAP4), 2022, Li et al

    SARS-CoV-2 Spike protein promotes vWF secretion and thrombosis via endothelial cytoskeleton-associated protein 4 (CKAP4) Kan Li, Liu Yao, Jin...
    Thread by: SNT Gatchaman, Sep 24, 2022 at 8:44 PM, 0 replies, in forum: Epidemics (including Covid-19, not Long Covid)
  3. SNT Gatchaman
    Thread

    COVID-19 patient fibrinogen produces dense clots with altered polymerization kinetics, ... increased sialic acid, 2022, Moiseiwitsch et al

    COVID-19 patient fibrinogen produces dense clots with altered polymerization kinetics, partially explained by increased sialic acid Moiseiwitsch...
    Thread by: SNT Gatchaman, Sep 22, 2022, 4 replies, in forum: Epidemics (including Covid-19, not Long Covid)
  4. Cheshire
    Thread

    Long-term neurologic outcomes of COVID-19, 2022, Al-Aly et al.

    The neurologic manifestations of acute COVID-19 are well characterized, but a comprehensive evaluation of postacute neurologic sequelae at 1 year...
    Thread by: Cheshire, Sep 22, 2022, 10 replies, in forum: Long Covid research
  5. SNT Gatchaman
    Thread

    Association of COVID-19 With Major Arterial & Venous Thrombotic Diseases: A Population-Wide Cohort Study of 48 million Adults in England & Wales, 2022

    Association of COVID-19 With Major Arterial and Venous Thrombotic Diseases: A Population-Wide Cohort Study of 48 Million Adults in England and...
    Thread by: SNT Gatchaman, Sep 21, 2022, 2 replies, in forum: Epidemics (including Covid-19, not Long Covid)
  6. Dolphin
    Thread

    (Europe) COVID-19 impact on healthcare management of people with chronic diseases

    I haven't fill this in myself so far. https://www.surveymonkey.com/r/8NWFDC2 COVID-19 impact on healthcare management of people with chronic...
    Thread by: Dolphin, Sep 13, 2022, 4 replies, in forum: Other health news and research
  7. John Mac
    Thread

    Larger gray matter volumes in neuropsychiatric long-COVID syndrome, Besteher et al, 2022

    Highlights Neuropsychiatric symptoms are common among long-COVID patients. • Cortical and subcortical gray matter volumes are increased in these...
    Thread by: John Mac, Sep 9, 2022, 0 replies, in forum: Long Covid research
  8. SNT Gatchaman
    Thread

    Long-term cardiac pathology in individuals with mild initial COVID-19 illness, 2022, Puntmann et al

    Long-term cardiac pathology in individuals with mild initial COVID-19 illness Valentina O. Puntmann, Simon Martin, Anastasia Shchendrygina,...
    Thread by: SNT Gatchaman, Sep 5, 2022, 5 replies, in forum: Long Covid research
  9. RedFox
    Thread

    Using an untargeted metabolomics approach to analyze serum metabolites in COVID-19 patients with nucleic acid turning negative

    Hot off the press, just published today in Frontiers in Pharmacology. A group of researchers in China used metabolomics (measuring the...
    Thread by: RedFox, Aug 24, 2022, 1 replies, in forum: Long Covid research
  10. SNT Gatchaman
    Thread

    Neurological and psychiatric risk trajectories after SARS-CoV-2 infection (2022, Taquet et al)

    Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437...
    Thread by: SNT Gatchaman, Aug 18, 2022, 6 replies, in forum: Long Covid research
  11. SNT Gatchaman
    Thread

    Early antithrombotic post-discharge therapy using prophylactic DOAC or dipyridamole improves survival and cardiovascular outcomes in COVID-19 (2022)

    Early antithrombotic post-discharge therapy using prophylactic DOAC or dipyridamole improves long-term survival and cardiovascular outcomes in...
    Thread by: SNT Gatchaman, Aug 15, 2022, 0 replies, in forum: Epidemics (including Covid-19, not Long Covid)
  12. Andy
    Thread

    Anti-neuronal antibodies against brainstem antigens are associated with COVID-19, 2022, Lucchese et al

    Summary Background Understanding how SARS-CoV-2 affects respiratory centres in the brainstem may help to preclude assisted ventilation for...
    Thread by: Andy, Aug 14, 2022, 0 replies, in forum: Epidemics (including Covid-19, not Long Covid)
  13. Andy
    Thread

    Protective Effects of BNT162b2 Vaccination on Aerobic Capacity Following Mild to Moderate SARS-CoV-2 Infection, 2022, Blumberg et al

    Abstract Patients previously infected with acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may experience post-acute adverse health...
    Thread by: Andy, Aug 13, 2022, 2 replies, in forum: Epidemics (including Covid-19, not Long Covid)
  14. SNT Gatchaman
    Thread

    [Preprint] Persistent Presence of Spike protein and Viral RNA in the Circulation of Individuals with Post-Acute Sequelae of COVID-19, 2022, Craddock+

    Persistent Presence of Spike protein and Viral RNA in the Circulation of Individuals with Post-Acute Sequelae of COVID-19 Vaughn Craddock, Aatish...
    Thread by: SNT Gatchaman, Aug 10, 2022, 3 replies, in forum: Long Covid research
  15. SNT Gatchaman
    Thread

    [Preprint] Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is common in post-acute sequelae of SARS-CoV-2 infection (PASC), 2022, Bonilla+

    Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is common in post-acute sequelae of SARS-CoV-2 infection (PASC): Results from a...
    Thread by: SNT Gatchaman, Aug 5, 2022, 2 replies, in forum: Long Covid research
  16. SNT Gatchaman
    Thread

    Mitochondrial Dysfunction: A Prelude to Neuropathogenesis of SARS-CoV‐2, 2022, Pliss et al

    Mitochondrial Dysfunction: A Prelude to Neuropathogenesis of SARS-CoV‐2 Artem Pliss, Andrey N. Kuzmin, Paras N. Prasad, Supriya D. Mahajan The...
    Thread by: SNT Gatchaman, Jul 29, 2022, 2 replies, in forum: Long Covid research
  17. leokitten
    Thread

    Impaired ketogenesis ties metabolism to T cell dysfunction in COVID-19, 2022, Karagiannis et al

    https://www.nature.com/articles/s41586-022-05128-8 Anorexia and fasting are host adaptations to acute infection, inducing a metabolic switch...
    Thread by: leokitten, Jul 28, 2022, 2 replies, in forum: Long Covid research
  18. SNT Gatchaman
    Thread

    Recovering or Persisting: The Immunopathological Features of SARS-CoV-2 Infection in Children, 2022, Buonsenso et al

    Recovering or Persisting: The Immunopathological Features of SARS-CoV-2 Infection in Children Buonsenso D, Valentini P, De Rose C, Tredicine M,...
    Thread by: SNT Gatchaman, Jul 28, 2022, 2 replies, in forum: Long Covid research
  19. LarsSG
    Thread

    Prognosis and persistence of smell and taste dysfunction in patients with covid-19: meta-analysis..., 2022, Toh et al

    Abstract Objective To clarify in patients with covid-19 the recovery rate of smell and taste, proportion with persistent dysfunction of smell and...
    Thread by: LarsSG, Jul 28, 2022, 4 replies, in forum: Long Covid research
  20. SNT Gatchaman
    Thread

    Rapidly evolving Creutzfeldt–Jakob disease in COVID-19: from early status epilepticus to fatal outcome, 2022, Olivo et al

    Rapidly evolving Creutzfeldt–Jakob disease in COVID-19: from early status epilepticus to fatal outcome Olivo, S., Furlanis, G., Buoite Stella, A....
    Thread by: SNT Gatchaman, Jul 25, 2022, 1 replies, in forum: Epidemics (including Covid-19, not Long Covid)
Showing results 1 to 20 of 226
Page 1 of 12